Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause

OBJECTIVE: Sleep disturbances are common among women in midlife; prevalence increases among perimenopausal/postmenopausal women with vasomotor symptoms. Paroxetine 7.5 mg is the only nonhormonal treatment that has been approved in the United States for moderate to severe vasomotor symptoms associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinkerton, JoAnn V., Joffe, Hadine, Kazempour, Kazem, Mekonnen, Hana, Bhaskar, Sailaja, Lippman, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott-Raven Publishers 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274337/
https://www.ncbi.nlm.nih.gov/pubmed/25137243
http://dx.doi.org/10.1097/GME.0000000000000311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274337/
https://www.ncbi.nlm.nih.gov/pubmed/25137243
http://dx.doi.org/10.1097/GME.0000000000000311

Ejemplares similares